Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). Tell your healthcare provider if you have liver or kidney problems, have diabetes or hemophilia, are allergic to sulfa medicines, or are pregnant, planning to become pregnant, or breastfeeding. CONTINUED BELOW
It starts when you team up with your doctor on an HIV treatment plan. Regular checkups and blood tests will show how well your medicine is working. Your treatment plan is more than just a list of medicines. You're setting the goals of your HIV treatment, including:
Viral load is the amount of HIV in your blood. The goal is a viral load so low that it's undetectable.
When treatment works well, your viral load goes DOWN and your CD4 cell count goes UP. There's less virus and more CD4 cells to help fight off diseases, infections, and AIDS-related illnesses.
A good HIV treatment plan will control the virus without causing too many side effects.
Meet your other partners, along with friends, family, and doctors: your medicines. These medicines work best in teams. There are four types of medicines that help keep HIV from making copies of itself in your CD4 cells:
Entry inhibitors change the lock on the cell. The chemical HIV uses as a key no longer works and the virus cannot enter the cell. There are two kinds of entry inhibitors: CCR5 inhibitors and fusion inhibitors (FIs).

Nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs): NRTIs and NNRTIs slow down the rate at which copies of HIV are made in the body.

These medicines slow down the production of integrase, the chemical HIV needs to enter the cell's command center and change the cell's machinery. Without this access, HIV cannot make copies of itself.

PIs stop protease from being produced. Protease is the chemical used by HIV to form the parts that need to be put together to make a new copy of the virus. When protease production is stopped, the virus cannot make copies of itself, so it cannot infect healthy cells. LEXIVA is a protease inhibitor. See how LEXIVA, a protease inhibitor, works.

Call it "adherence," "taking as directed," or simply "sticking with it." The most important part of your treatment plan is following it every day. That's the best way to increase your chances of fighting off illness. Getting off track can cause serious problems, including viral resistance.
There are plenty of obstacles to taking every dose, every day—from side effects to plain old forgetfulness. But getting your medicine shouldn't be one of them. Check out our programs that help with the cost of HIV medication: My Support Card and the GSK Assistance Program.
Sometimes during the course of HIV treatment, you may need to consider changing medicines. Here are possible reasons to change:
Different medicines may lower your viral load and keep you healthier. They may also cause fewer side effects. No matter what, do not make changes without consulting your healthcare provider. Together you will decide if safely changing medicines is right for you.
*Individual experiences may vary. By prescription only.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.